31 related articles for article (PubMed ID: 8622881)
1. Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy.
Jankovic M; Knezevic T; Tomic A; Milicevic O; Jovanovic T; Djunic I; Mihaljevic B; Knezevic A; Todorovic-Balint M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612552
[TBL] [Abstract][Full Text] [Related]
2. Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer.
Sofou S; Enmon R; Palm S; Kappel B; Zanzonico P; McDevitt MR; Scheinberg DA; Sgouros G
J Liposome Res; 2010 Dec; 20(4):330-40. PubMed ID: 20070139
[TBL] [Abstract][Full Text] [Related]
3. Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.
Ryu SY; Kim K; Lee WS; Kwon HC; Lee KH; Kim CM; Kang SB
J Gynecol Oncol; 2009 Mar; 20(1):48-54. PubMed ID: 19471670
[TBL] [Abstract][Full Text] [Related]
4. Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers.
Sofou S; Kappel BJ; Jaggi JS; McDevitt MR; Scheinberg DA; Sgouros G
Bioconjug Chem; 2007; 18(6):2061-7. PubMed ID: 17935286
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.
Cerezo L; Cárdenes H; Michael H
Clin Transl Oncol; 2006 Apr; 8(4):231-41. PubMed ID: 16648098
[TBL] [Abstract][Full Text] [Related]
6. Intravascular adenoviral agents in cancer patients: lessons from clinical trials.
Reid T; Warren R; Kirn D
Cancer Gene Ther; 2002 Dec; 9(12):979-86. PubMed ID: 12522437
[TBL] [Abstract][Full Text] [Related]
7. Genetic factors in ovarian carcinoma.
Li AJ; Karlan BY
Curr Oncol Rep; 2001 Jan; 3(1):27-32. PubMed ID: 11123866
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
9. p53 gene status and chemosensitivity in ovarian cancer.
Kigawa J; Sato S; Shimada M; Takahashi M; Itamochi H; Kanamori Y; Terakawa N
Hum Cell; 2001 Sep; 14(3):165-71. PubMed ID: 11774736
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma.
Mujoo K; Maneval DC; Anderson SC; Gutterman JU
Oncogene; 1996 Apr; 12(8):1617-23. PubMed ID: 8622881
[TBL] [Abstract][Full Text] [Related]
11. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
13. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
Song K; Cowan KH; Sinha BK
Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
Xie Y; Gilbert JD; Kim JH; Freytag SO
Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse.
Kim J; Hwang ES; Kim JS; You EH; Lee SH; Lee JH
Cancer Gene Ther; 1999; 6(2):172-8. PubMed ID: 10195884
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
